Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04337255 · ClinicalTrials.gov registry record · NA

Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients

A NA study of Stroke and Alzheimer Disease, sponsored by Rush University Medical Center.

Active
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT04337255: Active NA study of Stroke and Alzheimer Disease, sponsored by Rush University Medical Center.

NCT04337255 is a NA study of Stroke and Alzheimer Disease that is active but no longer recruiting, run by Rush University Medical Center. The registered enrollment target is 250 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04337255, a NA study of Stroke and Alzheimer Disease, is active but no longer recruiting, sponsored by Rush University Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

To test the effects of a 2- to 3-year intervention of the MIND diet versus usual post-stroke care on cognitive decline, the characteristic feature of dementia, and on brain biomarkers of Alzheimer's Disease (AD) and vascular disease in a Phase Ill randomized controlled trial of 250 patients hospitalized for acute ischemic stroke, aged 55 years or older, and without dementia who are discharged home following hospitalization.

Primary Outcome

3-year change in global cognitive score. The global cognitive score is a composite score, based on the average of z scores of the 19 individual tests scores, with a mean of 0 and standard deviation of 1. Higher scores reflect high global cognitive function.

Interventions

  • OTHER Behavioral Dietary intervention ( MIND Diet)
  • OTHER Behavioral Usual Care Diet Intervention

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2021-12-14
Est. Completion 2027-05-31
Phase NA
Rush University Medical Center

320 total trials

What the registry record for NCT04337255 still lists

NCT04337255 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower).

The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Dietary intervention ( MIND Diet) is the first listed.

NCT04337255 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04337255 about?

NCT04337255 is a clinical study titled "Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients". To test the effects of a 2- to 3-year intervention of the MIND diet versus usual post-stroke care on cognitive decline, the characteristic feature of dementia, and on brain biomarkers of Alzheimer's Disease (AD) and vascular disease in a Phase Ill randomized controlled trial of 250 patients hospital...

What is the current status of trial NCT04337255?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2021-12-14. Estimated completion is 2027-05-31.

What conditions does trial NCT04337255 study?

This clinical trial studies the following conditions: Stroke, Alzheimer Disease, Dementia, Cognitive Decline, Dementia, Vascular.

What interventions are being tested in trial NCT04337255?

The interventions under investigation include: Behavioral Dietary intervention ( MIND Diet) (OTHER), Behavioral Usual Care Diet Intervention (OTHER).

Who is sponsoring clinical trial NCT04337255?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04337255 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04337255's enrollment target sits among peer trials

250 86th of 454 higher than 366 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04337255, the US trial registry maintained by the National Library of Medicine. NCT04337255 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.